SEC FORM 5

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0362
Estimated average burden
hours per response:			1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

MATSCHULLAT ROBERT W

(Last)

(First)

(Middle)

1221 BROADWAY

(Street)

OAKLAND

946121888

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
06/30/2004

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock							2,648	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Units	$0.00	08/15/2003		J⁽¹⁾	39.03		⁽²⁾	⁽²⁾	Common Stock	39.03	$42.67	6,207.73	D
Deferred Stock Units	$0.00	09/30/2003		A⁽³⁾	599.52		⁽²⁾	⁽²⁾	Common Stock	599.52	$45.87	6,807.25	D
Deferred Stock Units	$0.00	11/14/2003		J⁽¹⁾	38.92		⁽²⁾	⁽²⁾	Common Stock	38.92	$47.22	6,846.17	D
Deferred Stock Units	$0.00	12/31/2003		A⁽³⁾	257.41		⁽²⁾	⁽²⁾	Common Stock	257.41	$47.87	7,103.58	D
Deferred Stock Units	$0.00	12/31/2003		A⁽⁴⁾	208.9		⁽²⁾	⁽²⁾	Common Stock	208.9	$47.87	7,312.48	D
Deferred Stock Units	$0.00	02/13/2004		J⁽¹⁾	40.82		⁽²⁾	⁽²⁾	Common Stock	40.82	$48.37	7,353.3	D
Deferred Stock Units	$0.00	03/31/2004		A⁽³⁾	1,277.86		⁽²⁾	⁽²⁾	Common Stock	1,277.86	$48.91	8,631.16	D
Deferred Stock Units	$0.00	05/14/2004		J⁽¹⁾	45.96		⁽²⁾	⁽²⁾	Common Stock	45.96	$50.7	8,677.12	D
Deferred Stock Units	$0.00	06/30/2004		A⁽³⁾	1,162.14		⁽²⁾	⁽²⁾	Common Stock	1,162.14	$53.78	9,839.26	D
Director Stock Option (Right to Buy) - 03AT	$42.65						07/01/2005⁽⁵⁾	07/01/2013	Common Stock	3,000		3,000	D

Explanation of Responses:

1. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Stock-Based Compensation Plan.

2. The Deferred Stock Units accrued pursuant to the Independent Directors' Stock-Based Compensation Plan will be settled 100% in Clorox stock upon the reporting person's retirement or other termination of service as a Director.

3. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fee pursuant to the Independent Directors' stock-Based Compensation Plan.

4. Annual $10,000 award of Deferred Stock Units pursuant to the Independent Directors' Compensation Plan.

5. Option exercisable in 3 equal installments - 1/3 on each of the first, second and third anniversaries of the grant date.

Remarks:

	By: Patrick M. Meehan, Assistant General Cousnel	08/16/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.